2026 Nobel Prize in Medicine to optogenetics, the light that reveals the brain

The Nobel Assembly at Karolinska Institutet has announced the winners of the 2026 Nobel Prize in Medicine: Karl Deisseroth, Peter Hegemann and Georg Nagel, awarded for discoveries on light-activated ion channels and for the development of the technique that emerged from them, optogenetics.

The awarded method makes it possible to observe, in real time, how nerve cells form memories, emotions and behaviors in the living brain: a development that has changed the way neuroscience studies the functioning of the central nervous system. The discoveries recognized by the Nobel committee were made at the Max Planck Institute for Biochemistry in Martinsried, Germany, where the three researchers carried out the work that was later awarded.

This year’s prize money amounts to 12 million Swedish kronor, approximately 1.2 million dollars, to be divided equally among the three winners.

Although optogenetics is now a widely used tool in neuroscience laboratories around the world, it remains a basic research technique: it allows the study of how neural circuits function, not the treatment of patients. This year’s award therefore recognizes a contribution to understanding the brain, not a therapy ready for clinical use. The distinction is relevant because optogenetics is sometimes presented in public debate as a possible path toward new treatments, while its use today remains confined to research laboratories.

The Nobel Prize in Medicine is the first of the verdicts in the 2026 Nobel week, which continues with the announcement for Literature and will conclude with the Economics prize on October 12. The three prizes awarded so far confirm the usual format: a separate ceremony for each discipline, a single purse divided among the winners when the recognition is shared.